| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8819669 | Journal of Cystic Fibrosis | 2018 | 6 Pages |
Abstract
Ivacaftor treatment reduces the frequency of PEx but does not improve on the rate of complete lung function recovery after PEx when compared with placebo.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Patrick A. Flume, Claire E. Wainwright, D. Elizabeth Tullis, Sally Rodriguez, Minoo Niknian, Mark Higgins, Jane C. Davies, Jeffrey S. Wagener,